There is considerable interest and concern about the cost of antiretroviral
regiments that are now widely advocated. Unfortunately, decisions about
specific drug regimens are sometimes determined by patient resources, pharmacy
plans and ADAP formularies. The following is a tabulation of costs based on
average wholesale prices (AWP), using standard doses, as of September 1996.
| Regimen |
|
Cost/year |
| ddI
|
|
$2,100 |
| d4T |
|
$2,800 |
| AZT + ddI |
|
$5,540 |
| AZT + 3TC |
|
$5,610 |
| AZT
+ ddC |
|
$5,720 |
Saquinavir + Ritonavir |
|
$8,220 |
Indinavir + AZT +
3TC |
|
$9,930 |
Nevirapine + AZT + 3TC |
|
$11,390 |
Saquinavir +
Ritonavir + AZT |
|
$11,620
|
Ritonavir + AZT + 3TC |
|
$11,815 |